­
­
­
­

Inventi Impact: Oncology

Articles

  • Inventi:hcc/19200/16
    Does the Degree of Hepatocellular Carcinoma Tumor Necrosis following Transarterial\nChemoembolization Impact Patient Survival?
    01-Jan-1970 Research 2016 : April - June
    Nathan Haywood, Kyle Gennaro, John Obert, Paul F Sauer Jr, David T Redden, Jessica Zarzour, J Kevin Smith, David Bolus, Souheil Saddekni, Ahmed Kamel Abdel Aal, Stephen Gray, Jared White, Devin E Eckhoff, Derek A DuBay

    Purpose. The association between transarterial chemoembolization- (TACE-) induced HCC tumor necrosis measured by the\nmodified Response Evaluation Criteria In Solid Tumors (mRECIST) and patient survival is poorly defined. We hypothesize\nthat survival will be superior in HCC patients with increased TACE-induced tumor necrosis. Materials and Methods. TACE\ninterventionswere retrospectively reviewed. Tumor response was quantified via dichotomized (responders and nonresponders) and\nthe four defined mRECIST categories. Results. Median survival following TACE was significantly greater in responders compared\nto nonresponders (20.8 months versus 14.9 months,

    How to Cite this Article
    CC Compliant Citation: Nathan Haywood, Kyle Gennaro, John Obert, et al., â??Does the Degree of Hepatocellular Carcinoma Tumor Necrosis\nfollowing Transarterial Chemoembolization Impact Patient Survival?,â? Journal of Oncology, vol. 2016, Article ID 4692139, 8 pages, 2016.\ndoi:10.1155/2016/4692139, http://creativecommons.org/licenses/by/4.0/.
    Download Full Text